Patents by Inventor Stavra A. Xanthakos

Stavra A. Xanthakos has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Biomarkers and methods for determining disease progression in nonalcoholic steatohepatitis (NASH)
    Patent number: 8871454
    Abstract: Diets high in saturated fat and fructose have been implicated in the development of obesity and nonalcoholic steatohepatitis (NASH) in humans. Provided herein are biomarkers, methods, and animal models useful for the investigation and non-invasive detection of NASH, including a non-invasive biomarker that could be used to establish disease severity, follow progression, and evaluate response to treatment in clinical trials for this increasingly prevalent disease.
    Type: Grant
    Filed: January 26, 2011
    Date of Patent: October 28, 2014
    Assignee: Children's Hospital Medical Center
    Inventors: Rohit Kohli, Stavra A. Xanthakos, Michael V. Miles
  • BIOMARKERS AND METHODS FOR DETERMINING DISEASE PROGRESSION IN NONALCOHOLIC STEATOHEPATITIS (NASH)
    Publication number: 20110212468
    Abstract: Diets high in saturated fat and fructose have been implicated in the development of obesity and nonalcoholic steatohepatitis (NASH) in humans. Provided herein are biomarkers, methods, and animal models useful for the investigation and non-invasive detection of NASH, including a non-invasive biomarker that could be used to establish disease severity, follow progression, and evaluate response to treatment in clinical trials for this increasingly prevalent disease.
    Type: Application
    Filed: January 26, 2011
    Publication date: September 1, 2011
    Inventors: Rohit Kohli, Stavra A. Xanthakos, Michael V. Miles